DE3886718D1 - Hydrogenierte Derivate von Antibiotika A/16686. - Google Patents

Hydrogenierte Derivate von Antibiotika A/16686.

Info

Publication number
DE3886718D1
DE3886718D1 DE88119001T DE3886718T DE3886718D1 DE 3886718 D1 DE3886718 D1 DE 3886718D1 DE 88119001 T DE88119001 T DE 88119001T DE 3886718 T DE3886718 T DE 3886718T DE 3886718 D1 DE3886718 D1 DE 3886718D1
Authority
DE
Germany
Prior art keywords
antibiotics
tetrahydroderivatives
hydrogenated derivatives
factors
hydrogenation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88119001T
Other languages
English (en)
Other versions
DE3886718T2 (de
Inventor
Romeo Ciabatti
Bruno Cavalleri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of DE3886718D1 publication Critical patent/DE3886718D1/de
Application granted granted Critical
Publication of DE3886718T2 publication Critical patent/DE3886718T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Dental Preparations (AREA)
DE88119001T 1987-12-23 1988-11-15 Hydrogenierte Derivate von Antibiotika A/16686. Expired - Fee Related DE3886718T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729989A GB8729989D0 (en) 1987-12-23 1987-12-23 Novel hydrogenated derivatives of antibiotic a/16686

Publications (2)

Publication Number Publication Date
DE3886718D1 true DE3886718D1 (de) 1994-02-10
DE3886718T2 DE3886718T2 (de) 1994-04-28

Family

ID=10628943

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88119001T Expired - Fee Related DE3886718T2 (de) 1987-12-23 1988-11-15 Hydrogenierte Derivate von Antibiotika A/16686.

Country Status (11)

Country Link
US (1) US5108988A (de)
EP (1) EP0321696B1 (de)
JP (1) JP2507573B2 (de)
KR (1) KR890009964A (de)
AT (1) ATE99329T1 (de)
CA (1) CA1338848C (de)
DE (1) DE3886718T2 (de)
DK (1) DK690288A (de)
ES (1) ES2061610T3 (de)
GB (1) GB8729989D0 (de)
IE (1) IE883840L (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621911D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
CA2250578C (en) 1996-04-23 2003-06-24 Versicor Inc. Improved chemical process for preparing amide derivatives of antibiotic a 40926
EP0976394A1 (de) * 1998-07-30 2000-02-02 Biosearch Italia S.p.A. Neue injizierbare Formulierungen
CA2476567A1 (en) * 2002-03-08 2003-09-18 Vicuron Pharmaceuticals Inc. A process for the production of ramoplanin-like amide derivatives
US7317001B2 (en) 2002-06-06 2008-01-08 Oscient Pharmaceuticals Corporation Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
WO2004096143A2 (en) * 2003-04-25 2004-11-11 Oscient Pharmaceuticals Corporation Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
US8252339B2 (en) * 2006-04-11 2012-08-28 Massachusetts Institute Of Technology Medical treatment applications of swellable and deformable microspheres
EP2604619A3 (de) * 2009-12-14 2014-01-22 University of Basel Mannosederivate als Antagonisten bakterieller Haftung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801629B (en) * 1979-04-07 1981-03-25 Lepetit Spa Antibiotic a/16686 and process for the preparation thereof
EP0046201B1 (de) * 1980-08-16 1984-04-11 Gruppo Lepetit S.P.A. Antibiotikum A/16686 Faktor A2, Verfahren zu dessen Herstellung und die gleichzeitig hergestellten Antibiotika A/16686 Faktoren A1 und A3
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686

Also Published As

Publication number Publication date
JP2507573B2 (ja) 1996-06-12
JPH01211600A (ja) 1989-08-24
EP0321696B1 (de) 1993-12-29
IE883840L (en) 1989-06-23
US5108988A (en) 1992-04-28
ES2061610T3 (es) 1994-12-16
ATE99329T1 (de) 1994-01-15
KR890009964A (ko) 1989-08-05
CA1338848C (en) 1997-01-14
DK690288A (da) 1989-06-24
EP0321696A2 (de) 1989-06-28
GB8729989D0 (en) 1988-02-03
DK690288D0 (da) 1988-12-12
EP0321696A3 (en) 1990-07-11
DE3886718T2 (de) 1994-04-28

Similar Documents

Publication Publication Date Title
DE68917163D1 (de) Antibakterielle Mittel.
KR930703355A (ko) 항생물질 ge2270 인자의 아미드
DE3886718D1 (de) Hydrogenierte Derivate von Antibiotika A/16686.
ATE156126T1 (de) Fungizides mittel, seine herstellung und mikroorganismus dafür
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ES2067493T3 (es) Agliconas de antibioticos a/16686.
ATE96845T1 (de) Teicoplaninaehnliche derivate.
NO932502D0 (no) Nye fosfolipidderivater
FI911191A0 (fi) 1-alkyl-, 1-alkenyl- och 1-alkynylaryl-2-amino-1,3-propandioler och motsvarande foereningar, foerfarande och mellanprodukter foer framstaellning av dessa och anvaendning av dessa som laekemedel.
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel
GR3004095T3 (de)
ATE167869T1 (de) Thiolderivate von gallensäure
ATE29257T1 (de) 2-oxoazetidinon-derivate, ihre herstellung und verwendung.
SU1455633A1 (ru) О,о-диизопропил-о-[1, 1-диметил-2-пропилтио-2-(о-о-диизопропилфосфорил)- имино]-этилфосфат, обладающий бактерицидной активностью

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOSEARCH ITALIA S.P.A., GERENZANO, IT

8327 Change in the person/name/address of the patent owner

Owner name: VICURON PHARMACEUTTICALS INC.(N.D.GES.STAATES DELA

8328 Change in the person/name/address of the agent

Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539 M

8339 Ceased/non-payment of the annual fee